Cancer is smart.
Together, we can
be smarter.
Accelerating the fight against cancer requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform.
Together, we can learn from the experience of every patient.
For Community Oncology
OncoCloud is the most comprehensive suite of software and services in community oncology. Using our technology, community clinics are providing better care for patients while remaining efficient, independent and financially successful.
Learn more
For Life Sciences
With access to billions of data points on millions of cancer patients treated across our network, Flatiron is changing the way life science companies are using real-world data to accelerate research and generate evidence.
Learn more
For Academics & Hospitals
Flatiron’s enriched data infrastructure helps hospitals and academic centers unlock the promise of their EHR data. Researchers and clinicians now have access to research-grade insights from within and beyond the walls of their institution.
Learn moreDo well by doing good. Join the leading tech company in the fight against cancer.
Life at Flatiron
The talent and dedication of the people working at Flatiron makes everything we do possible. If you’re passionate about having an impact on accelerating cancer research and improving patient care, we’d love to hear from you.
Open positionsLet us tell you more.
We will email you to start the conversation.
Association of Broad-Based Genomic Sequencing With Survival Among Patients with aNSCLC in the Community Setting
Published by JAMA, Flatiron’s data was used in collaboration with Yale Cancer Center to investigate survival in a lung cancer cohort receiving broad-based genomic sequencing.
Advancing the Use of Real-World Evidence with a Noteworthy Industry Collaborative Pilot Project
Friends of Cancer Research convened stakeholders across oncology to discuss a recent cross-industry collaboration to advance the use of real-world evidence.
Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers
Bristol-Myers Squibb and Flatiron Health expand their relationship with a three-year collaboration agreement to accelerate the company's research and development efforts.